Title : Combined treatment with lenalidomide and epoetin alfa in lower-risk patients with myelodysplastic syndrome.

Pub. Date : 2012 Oct 25

PMID : 22936658






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The erythropoietic effects of lenalidomide are cytokine dependent, suggesting that the erythroid hematologic improvement (HI-E) rate may be augmented by combined treatment (CT) with recombinant human erythropoietin (rhu-EPO) in myelodysplastic syndrome (MDS). Lenalidomide erythropoietin Homo sapiens
2 The erythropoietic effects of lenalidomide are cytokine dependent, suggesting that the erythroid hematologic improvement (HI-E) rate may be augmented by combined treatment (CT) with recombinant human erythropoietin (rhu-EPO) in myelodysplastic syndrome (MDS). Lenalidomide erythropoietin Homo sapiens